These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9833256)

  • 1. [Serologic diagnosis and follow-up of hepatitis B].
    Frei PC; Grob PJ
    Soz Praventivmed; 1998; 43 Suppl 1():S10-3, S84-7. PubMed ID: 9833256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical serological profiles in hepatitis B virus infection.
    Pondé RA
    Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):461-76. PubMed ID: 23192489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection.
    Noborg U; Gusdal A; Horal P; Lindh M
    Scand J Infect Dis; 2000; 32(3):249-52. PubMed ID: 10879593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in hepatitis B detection among blood donors.
    Allain JP; Cox L
    Curr Opin Hematol; 2011 Nov; 18(6):461-6. PubMed ID: 21912252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorrhagic vasculitis and the hepatitis B virus].
    Tareeva IE; Filimonova RG; Nikolaev AIu; Androsova SO; Mikhaĭlov MI; Miroshnichenko NG
    Ter Arkh; 1993; 65(6):17-9. PubMed ID: 8378839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
    Varaklioti A; Kouramba A; Ioannidou P; Katsarou O
    Infect Genet Evol; 2017 Oct; 54():397-401. PubMed ID: 28705716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis of Hepatitis A, B, C, D and E. Clinical, biochemical and viral serologic criteria. 3: Serology--hepatitis B].
    Eisenburg J
    Fortschr Med; 1995 Jan; 113(1-2):41-2, 45. PubMed ID: 7883265
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection.
    Thomas HI
    J Med Virol; 1997 Mar; 51(3):189-97. PubMed ID: 9139082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft.
    Lowell JA; Howard TK; White HM; Shenoy S; Huettner PC; Brennan DC; Peters MG
    Lancet; 1995 Apr; 345(8957):1084-5. PubMed ID: 7715341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exacerbation in chronic hepatitis B virus infection.
    Santos MV; Duarte MI; Barone AA
    Rev Soc Bras Med Trop; 1996; 29(3):275-9. PubMed ID: 8701048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicity.
    El-Ghitany EM; Farghaly AG
    J Virol Methods; 2013 Dec; 194(1-2):190-3. PubMed ID: 24004823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of hepatitis B virus carrier infants.
    Chan CY; Lee SD; Yu MI; Wang YJ; Tsai YT; Lo KJ
    J Med Virol; 1994 Dec; 44(4):336-9. PubMed ID: 7897365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1.
    Twagirumugabe T; Swaibu G; Walker TD; Lindh M; Gahutu JB; Bergström T; Norder H
    BMC Infect Dis; 2017 Jan; 17(1):32. PubMed ID: 28056881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.